文献速递眼底病与葡萄膜炎小儿眼科与斜弱视

烟碱型胆碱能通路参与早产儿视网膜病变小鼠模型的视网膜新生血管形成

The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

该研究在小鼠氧诱导缺血性视网膜病变模型中,比较出生后第14天与第17天烟碱型乙酰胆碱受体(nAChR)亚型及血管内皮生长因子(VEGF)信号通路组分的表达,并评估局部或眼内注射美加明或靶向敲除α7或α9 nAChR对缺血诱导视网膜新生血管的影响。结果显示缺血视网膜中nAChR亚基及VEGF信号通路组分表达增加,美加明减少视网膜新生血管且不影响正常血管发育,敲除α9而非α7减少新生血管。作者认为nAChR信号主要通过α9亚基参与缺血诱导的视网膜新生血管,美加明或特异性α9 nAChR拮抗剂可考虑用于治疗早产儿视网膜病变及其他缺血性视网膜病变。

要点

  • 缺血视网膜中nAChR亚基及VEGF信号通路组分表达增加。
  • 局部或眼内注射美加明减少缺血诱导的视网膜新生血管,不影响正常视网膜血管发育。
  • 靶向敲除α9而非α7 nAChR亚基减少缺血性视网膜新生血管。

核心结论

  • 数据提示nAChR信号主要通过α9 nAChR亚基参与缺血诱导的视网膜新生血管,但不参与视网膜血管发育。
  • 美加明或特异性α9 nAChR拮抗剂可考虑用于治疗早产儿视网膜病变及其他缺血性视网膜病变。

研究设计与样本

  • 研究采用小鼠氧诱导缺血性视网膜病变模型,比较出生后第14天与第17天暴露于75%氧气(出生后第7天至第12天)后回到室内空气的小鼠与同期暴露于环境氧气水平的小鼠幼崽。
  • 通过局部或眼内注射非特异性nAChR拮抗剂美加明,或靶向敲除α7或α9 nAChR,比较出生后第17天视网膜新生血管量以确定效果。

主要发现

  • 缺血视网膜中nAChR亚基及VEGF信号通路组分的表达增加。
  • 局部应用或眼内注射美加明减少该模型中的视网膜新生血管。
  • 美加明对正常视网膜血管发育或缺血性视网膜病变小鼠中央视网膜无灌注区血管再通无影响。
  • 靶向敲除α9而非α7 nAChR亚基减少缺血性视网膜病变小鼠的视网膜新生血管。

临床怎么用

  • 作者认为,美加明或特异性α9 nAChR拮抗剂可考虑用于治疗早产儿视网膜病变及其他缺血性视网膜病变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the role of nicotinic acetylcholine receptors (nAChRs) in retinal vascular development and ischemia-induced retinal neovascularization (NV). METHODS: The expression of nAChR subtypes and VEGF signaling pathway components was assessed in mice with and without oxygen-induced ischemic retinopathy by comparing expression levels at postnatal day (P) 14 and P17 in mice exposed to 75% oxygen from P7 to P12 and returned to room air versus mice pups that were exposed to ambient oxygen levels during the same period. The effect of topical or intraocular injection of mecamylamine, a nonspecific nAChR antagonist, or targeted deletion of α7- or α9-nAChRs on ischemia-induced retinal NV was determined by comparing the amount of retinal NV at P17 in these mice versus appropriate controls. RESULTS: The expression of nAChR subunits and components of the VEGF signaling pathways was increased in ischemic retina. Topical application or intraocular injection of mecamylamine decreased retinal NV in this model. Mecamylamine had no effect on normal retinal vascular development or on revascularization of the central retinal area of nonperfusion in mice with ischemic retinopathy. Targeted deletion of α9, but not α7, nAChR receptor subunits reduced retinal NV in mice with ischemic retinopathy. CONCLUSION: These data suggest that nAChR signaling, primarily through the α9 nAChR subunit, contributes to ischemia-induced retinal NV, but not retinal vascular development. Mecamylamine or a specific α9 nAChR antagonist could be considered for treatment of retinopathy of prematurity and other ischemic retinopathies.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Hackett SF, Seidel C, Abraham S, et al. The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity. Invest Ophthalmol Vis Sci. 2017. PMID: 28241318. doi:10.1167/iovs.16-20670

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。